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Objectives: Unrelated hematopoietic stem cell donors may donate twice. We studied donors’ preference
for peripheral blood stem cell (PBSC) collection or bone marrow (BM) harvest and compared the yields of
and side effects associated with two BM harvests.
Materials and Methods: Thepsychosocial andphysical experienceof13donorswhounderwent twodifferent
stem cell collection procedures and their preferences were collected via a self-reported questionnaire.
Among four donors who underwent two BM harvests, we compared the yields of and the side effects
associated with the ﬁrst and second harvest via chart review and self-reported questionnaire, respectively.
Results: The median recovery time associated with PBSC (1 day) was signiﬁcantly shorter than that
associated with BM harvest (7 days) (p< 0.01). Although most of the donors who underwent both
procedures felt that BM harvest was more physically demanding, caused more preprocedural anxiety,
was more time consuming, and was more inconvenient than PBSC collection, 63.6% of them preferred BM
donation. This preference for BM harvest over PBSC collection is different from previous studies. There
was no signiﬁcant difference in the yields of marrow nucleated cells (p¼ 0.25) and no signiﬁcant
differences in the incidence of side effects and recovery time between the ﬁrst and second BM donations.
Conclusion: Further understanding of donors’ preferences and reducing side effects associated with stem
cell harvesting procedures will help the registry improve its work.
Copyright  2011, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
All rights reserved.1. Introduction
The source of hematopoietic stem cells (HSCs) used for alloge-
neic transplantation has diversiﬁed over time. There are now three
choices, bone marrow (BM) HSC, peripheral blood stem cells
(PBSCs), and cord blood. They seem to have similar transplant
outcomes although the usage varies according to recipient’s age,
weight, and disease and donor’s preference. Recently, PBSC has
been increasingly used as the source of HSCs because of conve-
nience of collection, higher stem cell doses with faster engraftment,
and a potentially better graft versus leukemia effect. The National
Marrow Donor Program of the United States reported that PBSCand Oncology, Buddhist Tzu
, Hualien, Taiwan. Tel.: þ886
g).
ddhist Compassion Relief Tzu Chicomprised 72% of all stem cell donations in 2007 [1]. Although PBSC
collection is generally considered safer than BM harvest for adult
donors, there are still many complications of granulocyte-colony
stimulating factor (G-CSF)-mobilized PBSC harvest, including G-
CSF-related side effects, vessel access-related disorders, and
apheresis-related illness. However, it is difﬁcult to compare these
two stem cell collection procedures according to different donors’
experience. There is little discussion comparing BM and PBSC
donations from the donors’ psychosocial experiences.
A second donation from the same donor is requested in cases of
graft failure, a decrease in donor chimerism, or disease relapse. The
impact of a second HSC donation on the harvest yields and side
effects has not been well addressed. In this study, we evaluated the
impact of stem cell donations on a cohort of donors who donated
HSCs at least twice either by BM harvest, PBSC collection, or both.
Data on the psychosocial implications and side effects were gath-
ered via a self-reported questionnaire. We also evaluated the yields
of and side effects associated with two BM harvests.Foundation. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Questionnaire for donors experiencing both BM and PBSC harvest
Questionnaire
First, which type of donation was physically more difﬁcult?
Second, which type of donation made you more nervous prior procedure?
Third, which type of donation spent more of your time?
Fourth, which type of donation was more convenient?
Fifth, if you are ask to donate again, which type of donation would be
your ﬁrst choice and why?
Sixth, if your family member was requested to donate hematopoietic
stem cell, which method would you recommend?
Seventh, was there any headache, lower back pain, hip pain, pain at
puncture sites, pain in other site, difﬁcult walking, fatigue, or other
side effect related to the donation?
Eighth, how long did them take to recovery?
Ninth, was it hard for you to make the decision of doing second donation?
Tenth, were there any family member or friend against you
doing second donation?
BM¼ bone marrow; PBSC¼ peripheral blood stem cell.
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2.1. Institutional policy
According to our regulations forHSCdonation, a single donor can
make nomore than three donations, including BM stem cells, PBSC,
and lymphocytes. Donors are limited to one G-CSF-mobilized PBSC
donation because of safety concerns with G-CSF. The method by
which the HSC were harvested for the second donation was based
both on the donor’s preference and our regulations on donation.
2.2. Donors and procedures
Consecutive unrelated donors who had made more than one
donation of stem cells at Buddhist Tzu-Chi Stem Cell Center
(BTCSCC) fromMay 1994 toMay 2009were enrolled in this study. A
total of 17 of the 1738 volunteer donors underwent second HSC
donations. The harvests were performed by a standard operating
procedure at two hospitals afﬁliated with the Buddhist Compassion
Relief Tzu-Chi foundation. Informed consent was obtained from
every donor before the procedure. This study was approved by the
Institutional Review Board of our hospital.
2.3. BM harvest
The BM harvest procedure was performed as in our previous
report [2]. Under general anesthesia, marrowwas collected from the
bilateral posterior iliac crests using a single-hole needle technique
beforeMarch2002and amultiple-hole aspirationneedle afterMarch
2002. The targeted volume of BM collection was 20mL/kg of the
recipient’s body weight. All BM donors were hospitalized for 2 days.
2.4. PBSC harvest
G-CSF (ﬁlgrastim, Kirin Brewery Co, Tokyo, Japan) 10 mg/kg/
d was administered subcutaneously on a daily basis for 5 days at
local clinics to mobilize circulating stem cells [3]. Vascular access
was obtained via either two antecubital veins with 16e18 gauge
catheters or one antecubital vein with a 16e18 gauge catheter plus
one radial artery with a 20 gauge catheter. Generally, venous
catheterization was the ﬁrst choice. If two venous accesses were
difﬁcult to obtain (according to the evaluation of a physician or after
more than three attempts), an arterial access was then performed.
If peripheral vessel access was very difﬁcult, a central venous
catheter was placed via the femoral vein. The processed blood
volume was based on the recipient’s body weight as follows: 12 L
for recipients weighing less than 35 kg, 15 L for those weighing
from 35 kg to 45 kg, and 18 L for recipients weighing more than
45 kg. Large volume leukapheresis was used using a continuous-
ﬂow cell separator (Cobe Spectra, Cobe Laboratories, Denver, CO) at
a ﬂow rate of 40e60/min. If the CD34þ cell dose was less than
5106/kg of the recipient weight, a second collection with 6 L of
blood was performed the morning of the following day. All PBSC
donors spent 1 day in the hospital.
Donor characteristics, reasons for and type of second HSC
donation, and the yields from BM harvest were abstracted from the
medical records. Donors who underwent two different HSC
collection procedures (BM and PBSC) were given a 10-item ques-
tionnaire comparing differences in the side effects and recovery
time between the two procedures, the level of inconvenience
associated with the two procedures, and their preference for one
procedure over the other. The questionnaire is illustrated in Table 1.
Donors who underwent two BM harvests were given a question-
naire comparing the side effects and recovery time between the
ﬁrst and the second procedure. The side effects, including bonepain, fatigue, headache, dizziness, vomiting, and difﬁculty walking,
were graded as none, mild, moderate, or severe. Both question-
naires also contained two psychosocial questions; “Was it difﬁcult
for you to make the decision to donate a second time?” and “Did
any of your family members or friends disapprove of your decision
to donate a second time?” Cover letters explaining the study,
consent forms, and questionnaires were delivered to donors via
volunteers of the BTCSCC Donor Care Group. All donors agreed to
participate in the study and returned the questionnaire.
2.5. Statistics
The side effects associated with BM and PBSC harvest were
compared by the c2 test. The yields of the two BM harvests were
compared using the Wilcoxon test. A p value less than 0.05% was
considered signiﬁcant.
3. Results
3.1. Donor characteristics
A total of 17 of the 1738 unrelated donors (0.98%) underwent
second stem cell donations. The ﬁrst procedures included BMharvest
in12donorsandPBSCcollection in5donors.Among these17donors,4
underwent two BM harvests and 13 underwent one BM harvest and
onePBSCcollection. In addition, 5of the17donorsdonated the second
collection of HSC to different recipients and the other 12 donors
donated to the samepatient on both occasions. The indications for the
second donation from these 12 donors were graft failure (5 of 12; 41.7
%) and disease relapse (7 of 12; 58.3%). Among the ﬁve patients with
graft failure, two had severe aplastic anemia, one had chronicmyeloid
leukemia, one had acute myeloid leukemia, and one had non-Hodg-
kin’s lymphoma. Disease relapse occurred in four patients with acute
lymphoblastic leukemia, two patients with acute myeloid leukemia,
and one with non-Hodgkin’s lymphoma. The 13 donors who experi-
enced one BM harvest and one PBSC collection were followed up
annually with hemograms, biochemistry, and assessment of relevant
health condition after PBSC donation and all were physicallywell. The
four donors who experienced two BM harvests were followed up
annually with hemograms, biochemistry, and assessment of relevant
health condition for 3 years and they were all well.
3.2. Psychosocial and physical experience of donors who underwent
two stem cell donations
The side effects and recovery time among the 13 donors who
underwent a BM harvest procedure and a PBSC collection are
Table 2
Side effects of BM versus PBSC donation from the experience of donors who had
donated both (n¼ 13)
Side effects Percentage p
Headache
BM 0 0.42
PB 23.1
Fatigue
BM 46.2 0.18
PB 84.6
Bone pain
BM 69.2 0.12
PB 46.2
Dizziness
BM 23.1 0.5
PB 30.8
Insomnia
BM N/A N/A
PB 7.7
Vomiting
BM 0 N/A
PB 0
Difﬁculty in walking
BM 38.5 N/A
PB N/A
Median recovery time (d)
BM 7 <0.01
PB 1
BM¼ bone marrow; N/A¼ not available; PBSC¼ peripheral blood stem cell.
S.-H. Chen et al. / Tzu Chi Medical Journal 23 (2011) 16e1918summarized in Table 2. There were no signiﬁcant differences in
incidence of headache, fatigue, bone pain, dizziness, or vomiting
between the two procedures. The median recovery time, however,
was signiﬁcantly shorter for PBSC collection than for BM harvest (1
day vs. 7 days, p< 0.01). Althoughmost of these donors reported that
BM harvest was more physically demanding, caused more pre-
procedural anxiety, was more time consuming, and was more
inconvenient than PBSC collection, 63.6 % (7/11) donors reported that
they would choose the BM harvest if they were asked to donate one
more time. The detailed preferences and reasons of these 13 donors
are illustrated in Table 3. Three donors (numbers 6, 12, and 13)
reported that they preferred BM harvest because it was simple and
rapid, and therewas less pain during general anesthesia. Four female
donors (number 4, 5, 7, and 10) complained of discomfort during
placement of vascular access and PBSC apheresis. Three of these four
female donors weighed only 53 kg, 48 kg, and 47 kg and peripheral
vessel access was attempted 8, 8, and 10 times, respectively.Table 3
The preference type of donation in 13 donors experiencing both BM and PBSC donation
Donor Type of
ﬁrst donation
Time of ﬁrst
donation
Interval between
two donations (mo)
Gender/age
(yr)
BW
(kg)
P
p
1 PBSC Aug 2006 5 M/29 70 P
2 PBSC Mar 2007 2 F/44 62 N
3 PBSC Oct 2006 11 M/28 68 P
4 PBSC Sep 2007 20 F/38 53 B
5 PBSC Jan 2005 9 F/24 48 B
6 BM Nov 2003 17 F/48 48 B
7 BM Oct 2004 11 F/31 47 B
8 BM Oct 2003 32 M/29 55 P
9 BM Apr 2003 40 F/28 48 N
10 BM Nov 2001 60 F/42 60 B
11 BM Sep 2002 67 F/31 104 P
12 BM Aug 2007 13 M/27 65 B
13 BM Mar 2009 1 M/28 86 B
BM¼ bone marrow; BW¼ body weight; N/A¼ not available; PBSC¼ peripheral blood stIn contrast to the donor’s preference, 53.8% (7/13) donors
reported that they would recommend PBSC donation to their
relatives or friends when they wanted to donate HSC. Donors 2 and
9 followed the request of the transplant center when they were
asked for subsequent donations but they recommended PBSC for
their relative or friends’ donations. Number 7 donor thought BM
harvest was tolerable for her but probably would not be tolerable
for others, and therefore she recommended PBSC to others.
One-third (5/15) of the donors had difﬁculty before they
donated HSC for the second time. Ten of the 17 donors who
underwent two HSC donations encountered discouragement from
relatives or friends.
3.3. Two BM harvests
There were no signiﬁcant differences in the yields between the
ﬁrst and second BM harvests (p¼ 0.25). There were also no differ-
ences in side effects or recovery time between the ﬁrst and second
BM harvests. The donor characteristics and BM yields are summa-
rized in Table 4. The median time interval between the ﬁrst and
second BM donations was 1.6 years (0.4e3.2 years).
4. Discussion
In Taiwan, the BTCSCC opened in 1993 and is now one of themost
active HSC registries in Asia. We performed the ﬁrst unrelated BM
harvest inMay1994and theﬁrstG-CSF-mobilizedPBSCwascollected
in August 2003. There are 320,000 potential HSC volunteer donors in
the registry of the BTCSCC, and since its establishment, more than
1100 BM harvests and more than 700 PBSC collections have been
performed (latest updateMay2009). Thegoal of our stemcell registry
is to ensure that stem cells are safely collected with a sufﬁcient
number of progenitor cells. So, this study aimed to compare the
experiences of donors who underwent both BM and PBSC. The
harvest outcomes of two BM donations were also analyzed.
BM harvest is associated with anesthesia- and transfusion-
related risks as well as operative complications, such as wound pain
and infections. PBSC collections are associated with G-CSF-related
side effects and problems with apheresis procedures, such as difﬁ-
cult vascular access and citrate toxicity. The side effects of G-CSF
injection include bone pain, fatigue, headache, insomnia, and other
ﬂu-like symptoms. However, these symptoms are mostly transient
and tolerable. The long-term effects of G-CSF in individuals have not
been studied completely; therefore, donors are permitted to
undergo a PBSC collection only once in a lifetime according to our
present regulations. The maximum number of PBSC donationss
ersonal
reference
Reason for personal
preference
Recommend type for
relatives or friends
BSC N/A PBSC
/A As request by transplant center PBSC
BSC PBSC: rapid recovery PBSC
M Discomfort during PBSC procedure BM
M Discomfort during PBSC procedure BM
M BM: simple, rapid, painless during
anesthesia
BM
M Discomfort during PBSC procedure PBSC
BSC PBSC: rapid recovery PBSC
/A As request by transplant center PBSC
M Discomfort during PBSC procedure BM
BSC PBSC: rapid recovery PBSC
M BM: simple, rapid, painless during
anesthesia
BM
M BM: simple, rapid, painless during anesthesia BM
em cell.
Table 4
Donor characteristics and BM yields of 4 donors with twice BM harvest
Donor TNC 1 (108) TNC 2 (108) V 1(mL) V 2(mL) Density 1 (108/mL) Density 2 (108/mL) Age 1 BH 1 BW 1 Interval (mo)
1, male 276 353 1040 1004 0.2654 0.3516 41 165 78 17
2, male 134 157.5 1084 985 0.1236 0.1599 25 172 70 5
3, male 131 151 1043 1035 0.1256 0.1459 20 172 54 22
4, male 207 195 1013 1038 0.2043 0.1879 33 171 76 38
Median 170.5 176.2 1041 1019 0.165 0.174
p 0.25 0.38 0.25
1¼ ﬁrst harvest; 2¼ second harvest; BH¼ body height; BW¼ body weight; density¼ TNC/volume; TNC¼ total nucleated cell; V¼ harvest volume.
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Marrow Registry, Anthony Nolan Trust, and Spanish National Donor
Registry allow donors to donate PBSC twice.
In our study, the most common self-reported side effects of BM
harvest were bone pain (69.2%), fatigue (46.2%), and difﬁculty in
walking (38.5%). The most common side effects of PBSC were
fatigue (84.6%), bone pain (46.2%), dizziness (30.8%), and headache
(23.1%). Karlsson et al [4] reported that 85% of BM donors experi-
enced moderate or severe pain compared with 68% of PBSC donors,
and 49% of BM donors experienced severe fatigue compared with
16% of PBSC donors. Their ﬁndings that bone pain occurred more
frequently after BM harvest than after PBSC collection were similar
to our study. However, in our study, fatigue occurred more
frequently among PBSC donors than among those who underwent
BM harvest, which was different from other studies [4,5].
In 2001, Switzer et al [5] studied the psychosocial and physical
experiences of donors who underwent PBCS after having under-
gone a BM harvest. They showed the BM procedure was physically
demanding, time-consuming, and inconvenient and that only 20%
of donors (5 of 25) preferred BM harvest to PBSC donation. Another
study in 1996 demonstrated similar ﬁndings. Among 13 family
donors who subsequently donated BM and PBSCs, only one donor
preferred BM harvest to PBSC collection [6]. In contrast to these
studies, 63.6% (7 of 11) of our donors preferred BM harvest. Three
donors reported that they liked the rapidity and simplicity of the
BM harvest procedure and they experienced less discomfort during
harvest with general anesthesia. Four female donors disliked the
side effects during PBSC apheresis, which may have been related to
the discomfort caused by the establishment of vascular access and
problems with large volume apheresis. In our observations, female
donors did have higher rates of adverse events with PBSC collec-
tion, which is consistent with the ﬁndings reported by Pulsipher
et al [7]. The preference difference between our study and others
might be related to the discomforts of our PBSC collection. To
decrease the number of vascular access trials, ﬁxed experienced
medical staff have performed the placement of vascular access in
the past 2 years. Since November 2007, calcium gluconate supple-
mentation has been administered concomitantly during apheresis
to reduce citrate toxicity. In July 2009, we set up maximum pro-
cessing blood volumes for the ﬁrst day according to the donor’s
weight to avoid discomfort associated with large volume apheresis
for donors with low body weights. In addition to discomfort from
our PBSC procedure, the small case numbers and social or cultural
differences between Taiwan and Western countries may also have
contributed to this different preference. We need further larger
case numbers and comprehensive studies to elucidate the reasons.
Switzer et al [5] reported that 79% of donors did not have
difﬁculty in making the decision to donate again and only 33% of
donors had been discouraged by others. Sixty-six percent of our
donors had no difﬁculty in making the decision to donate HSC for
a second time, although 59% of donors had been discouraged by
relatives or friends from doing so. Further thorough educational
activities in the community may decrease misunderstandings andunrealistic medical concerns regarding the risks of BM or PBSC
harvest. Through these endeavors, we hope more donors will have
a strong intrinsic commitment to donate HSCs with less disagree-
ment from relatives and friends.
The median time interval between the ﬁrst and second BM
donation for the four donors with two BM harvests was 1.6 years
(0.4e3.2 years). There were no signiﬁcant differences in total
nucleated cell yield and marrow cell density between the ﬁrst and
second BM harvest (170.5108 vs. 176.2108, p¼ 0.25 and
0.165108/mL vs. 0.174108/mL, p¼ 0.25, respectively). There
were also no differences in side effects or recovery time between
the ﬁrst and second BM harvests. Although Stroncek et al [8] and
Akiyama et al [9] both demonstrated no signiﬁcant difference in
complications in the second BM harvest, the nucleated cell yield
was lower. This might be related to the younger age of our donors
(median age 29 years old) and the small case number in our study.
Although the case number in this study was relatively small, the
preference for BM harvest among donors differs from that reported
inprevious studies despite similar side effects. Discomfortswith our
PBSC apheresis procedure could be the reason and should be
improvedﬁrst.We think that decreasing the process volume in low-
bodyweight donors, using skilledmedical staff to establish vascular
access, and more aggressive supplementation with calcium gluco-
nate may further decrease the adverse events associated with the
apheresis procedure in the future. Further understanding of donors’
preferences and reducing side effects associated with stem cell
harvesting procedures will help the registry improve its work.
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